V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005413 | 220002116 | 1.67 | 80.9 | Palliative (P) | 2013-07-02 | 2013-07-02 | Trial Unspecified | 01 | null | 220028136 | TRIAL |
| 220005414 | 220011144 | 1.55 | 84.8 | Disease modification (D) | 2014-05-29 | 2014-06-10 | LI-1 TRIAL | Y | N | 220028137 | TRIAL |
| 220005415 | 220011144 | null | 65 | Curative (C) | 2013-05-06 | 2013-05-06 | AML17 TRIAL | Y | null | 220028137 | AML17 TRIAL |
| 220005416 | 220002117 | 1.83 | 76 | Curative (C) | 2017-01-25 | 2017-01-25 | AML17 TRIAL | 1 | null | 220028139 | AML17 TRIAL |
| 220005417 | 220002117 | 1.54 | 50 | Not known (9) | 2014-11-18 | 2014-11-18 | AML17 TRIAL | null | N | 220028139 | AML17 TRIAL |
| 220005418 | 220002117 | 1.66 | null | Palliative (P) | 2013-07-06 | 2013-07-26 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028139 | CYTARABINE |
| 220005419 | 220002118 | 1.7 | 77.1 | Curative (C) | 2015-03-11 | 2015-03-11 | Cytarabine Low Dose | 2 | N | 220028146 | CYTARABINE |
| 220005420 | 220002118 | 0 | 62 | Curative (C) | 2015-12-09 | 2015-12-09 | Trial Unspecified | N | N | 220028146 | TRIAL |
| 220005421 | 220002118 | 1.64 | 80 | Curative (C) | 2015-01-30 | 2015-02-04 | AML17 TRIAL | 02 | N | 220028146 | AML17 TRIAL |
| 220005422 | 220002118 | 1.78 | 56 | Curative (C) | 2017-12-22 | 2017-12-27 | Trial Unspecified | Y | N | 220028146 | TRIAL |
| 220005423 | 220002119 | 1.78 | 54 | Curative (C) | 2013-11-20 | 2014-05-07 | AML17 TRIAL | Y | N | 220028151 | AML17 TRIAL |
| 220005424 | 220002120 | null | 70 | Curative (C) | 2016-03-29 | 2016-04-19 | LI-1 TRIAL | Y | N | 220028152 | TRIAL |
| 220005425 | 220002120 | 0 | 78.1 | null | 2017-01-02 | 2017-01-02 | AML17 TRIAL | Y | N | 220028152 | AML17 TRIAL |
| 220005426 | 220002120 | 1.63 | 99 | Curative (C) | null | 2016-11-30 | AML17 TRIAL | null | null | 220028152 | AML17 TRIAL |
| 220005427 | 220018746 | 1.78 | 51.5 | Palliative (P) | 2017-07-10 | 2017-07-17 | CYTARABINE | 2 | N | 220028164 | CYTARABINE |
| 220005428 | 220018746 | 1.82 | 88 | Curative (C) | 2016-05-14 | 2016-05-14 | AML17 TRIAL | N | N | 220028164 | AML17 TRIAL |
| 220005429 | 220018746 | 0 | null | null | 2016-10-15 | 2016-10-26 | CYTARABINE | N | N | 220028164 | CYTARABINE |
| 220005430 | 220021712 | null | 81.5 | Disease modification (D) | 2017-05-13 | 2017-05-20 | Cytarabine Low Dose | N | N | 220028169 | CYTARABINE |
| 220005431 | 220021712 | 1.67 | 67.2 | Curative (C) | 2013-04-19 | 2013-04-19 | AML17 TRIAL | 01 | N | 220028169 | AML17 TRIAL |
| 220005432 | 220002121 | null | 78.9 | Palliative (P) | 2013-12-25 | 2013-12-27 | CYTARABINE | 2 | N | 220028172 | CYTARABINE |
| 220005433 | 220002121 | 1.58 | 80 | Curative (C) | 2014-05-16 | 2014-05-16 | AML17 TRIAL | 1 | N | 220028172 | AML17 TRIAL |
| 220005436 | 220002123 | null | 84 | Curative (C) | 2017-06-14 | 2017-06-14 | AML17 TRIAL | 01 | N | 220028180 | AML17 TRIAL |
| 220005437 | 220011150 | null | 62.3 | Palliative (P) | 2013-03-08 | 2013-03-09 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220028182 | CYTARABINE |
| 220005438 | 220011150 | 1.71 | 86.1 | Curative (C) | 2013-05-24 | 2013-05-24 | Trial Unspecified | Y | N | 220028182 | TRIAL |
| 220005439 | 220002124 | 1.71 | 54 | Curative (C) | 2013-09-26 | 2013-10-07 | AML17 TRIAL | N | N | 220028184 | AML17 TRIAL |
| 220005440 | 220002125 | 1.57 | null | Curative (C) | 2017-10-18 | 2017-10-29 | LI-1 TRIAL | N | N | 220028186 | TRIAL |
| 220005441 | 220011151 | 1.56 | 55.8 | Palliative (P) | null | 2017-09-16 | CYTARABINE | 2 | N | 220028187 | CYTARABINE |
| 220005442 | 220002126 | 1.8 | 0 | Curative (C) | 2014-02-19 | 2014-02-19 | LI-1 TRIAL | 1 | N | 220028190 | TRIAL |
| 220005443 | 220002127 | 1.62 | 81 | Palliative (P) | 2014-04-15 | 2014-04-15 | Cytarabine Low Dose | 2 | N | 220028191 | CYTARABINE |
| 220005444 | 220011152 | 1.81 | 73.899 | Curative (C) | 2013-10-01 | 2013-10-01 | AML17 TRIAL | 01 | N | 220028195 | AML17 TRIAL |
| 220005445 | 220011152 | 1.63 | 91.8 | Curative (C) | 2014-06-29 | 2014-06-29 | AML17 TRIAL | Y | N | 220028195 | AML17 TRIAL |
| 220005446 | 220002128 | 1.81 | 65.4 | Radical (R) | 2015-01-27 | 2015-01-27 | AML17 TRIAL | N | N | 220028201 | AML17 TRIAL |
| 220005447 | 220002128 | null | 64.1 | Disease modification (D) | 2015-09-08 | 2015-09-08 | Trial Unspecified | Y | null | 220028201 | TRIAL |
| 220005448 | 220002128 | 1.63 | 82.3 | Curative (C) | 2017-05-15 | 2017-05-22 | AML17 TRIAL | Y | N | 220028201 | AML17 TRIAL |
| 220005449 | 220002129 | 1.61 | 110 | Curative (C) | 2013-05-31 | 2013-05-31 | LI-1 TRIAL | Y | N | 220028207 | TRIAL |
| 220005450 | 220011154 | 1.51 | 0 | Palliative (P) | 2015-01-31 | 2016-01-31 | CYTARABINE | N | N | 220028209 | CYTARABINE |
| 220005451 | 220002130 | 1.69 | 0 | null | 2014-03-23 | 2014-03-26 | CYTARABINE | N | N | 220028211 | CYTARABINE |
| 220005452 | 220002131 | 1.78 | 62 | Curative (C) | 2014-01-15 | 2014-01-15 | CYTARABINE | N | N | 220028213 | CYTARABINE |
| 220005453 | 220002131 | 1.82 | 66.8 | Curative (C) | 2016-12-18 | 2016-12-18 | LI-1 TRIAL | 01 | N | 220028213 | TRIAL |
| 220005454 | 220002132 | 1.85 | null | Curative (C) | 2016-11-08 | 2016-12-17 | AML17 TRIAL | Y | N | 220028217 | AML17 TRIAL |
| 220005455 | 220002133 | 1.7 | null | Palliative (P) | 2016-03-02 | 2016-03-02 | Cytarabine Low Dose | 1 | null | 220028219 | CYTARABINE |
| 220005456 | 220002134 | null | 106.3 | Disease modification (D) | 2015-01-25 | 2015-01-25 | Trial Unspecified | Y | N | 220028220 | TRIAL |
| 220005457 | 220002134 | 1.69 | 86.5 | Not known (9) | 2017-01-05 | 2017-01-05 | AML17 TRIAL | N | N | 220028220 | AML17 TRIAL |
| 220005458 | 220002135 | 1.7 | null | Curative (C) | 2015-02-22 | 2015-02-22 | AML17 TRIAL | 01 | N | 220028227 | AML17 TRIAL |
| 220005459 | 220002135 | 1.75 | 97.3 | Adjuvant (A) | 2017-08-07 | 2017-08-07 | AML17 TRIAL | 02 | N | 220028227 | AML17 TRIAL |
| 220005460 | 220015973 | 1.53 | 82 | Curative (C) | 2016-10-13 | 2016-10-14 | LI-1 TRIAL | 1 | null | 220028229 | TRIAL |
| 220005461 | 220002136 | 1.76 | 79.9 | Curative (C) | 2016-12-06 | 2016-12-07 | AML17 TRIAL | N | N | 220028231 | AML17 TRIAL |
| 220005462 | 220002136 | 1.47 | 75 | Curative (C) | 2016-10-21 | 2016-10-23 | AML17 TRIAL | 02 | N | 220028231 | AML17 TRIAL |
| 220005463 | 220002136 | 0 | null | Curative (C) | 2015-01-25 | 2015-01-25 | LI-1 TRIAL | Y | N | 220028231 | TRIAL |
| 220005464 | 220018747 | 1.62 | null | Disease modification (D) | null | 2014-06-29 | Cytarabine low (10to20mg/m2) IV/SC | null | null | 220028243 | CYTARABINE |